High Note Wealth’s ResMed RMD Stock Holding History

High Note Wealth’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$449	Sell	2 -1	-33%	-$249	﹤0.01%	898
2025 Q4	$723	Buy	+3	New	+$767	﹤0.01%	833

Other funds holding RMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

High Note Wealth's RMD Position: Q1 2026 in Review

High Note Wealth reduced its ResMed (RMD) stake by 33% in Q1 2026, selling an estimated $249 and leaving 2 shares worth $449. The position accounts for ﹤0.01% of the portfolio, ranked #898.

High Note Wealth first reported a position in RMD in Q4 2025 and has held it in 2 quarters since. The position peaked at $723 in Q4 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

High Note Wealth held 2 shares of ResMed worth $449 as of Q1 2026.
High Note Wealth sold 1 ResMed share in Q1 2026, an estimated $249.
ResMed made up ﹤0.01% of High Note Wealth's portfolio in Q1 2026, its #898 holding.
High Note Wealth first reported a position in ResMed in Q4 2025 and has held it in 2 quarters since.
High Note Wealth's ResMed position peaked at $723 in Q4 2025.
938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on High Note Wealth's 13F filing for Q1 2026, filed 11 May 2026.